Hour9 Launches AI Automation Agency with Process-First Approach, Challenging Assumption That Businesses Should Maximize AI Integration 
Sixty-Six Capital Expands Effective Bitcoin Exposure with Option for up to 200 BTC and Move to Direct Holdings 
NTG Clarity to Announce Second Quarter Financial Results on August 27, 2026 with Earnings Call to Follow 
SonicStrategy Reports Q2 2026 Staking Revenue and Reduced Monthly Burn 
QSE Closes Second Tranche of Private Placement of $6 Million Sensata Technologies Announces Strategic Collaboration with NIRA Dynamics to Develop Tire Tread Depth Monitor Solution
Sensata’s new tire Tread Depth Monitoring (TDM) solution, powered by NIRA Dynamics’ tread wear estimation…
OXIO Raises $40 Million to Launch in the U.S. and Brazil; Introduces Telecom-as-a-Service to Turn Established Brands into Telecom Carriers
Backed by Web3 Investors, Including ParaFi Capital, Digital Currency Group and Multicoin Capital, OXIO Raises…
BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022
MAINZ, GERMANY, March 16, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the…
Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support Key Quicksome™ Vaccine and Cold Chain Projects
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
LIXTE Biotechnology Holdings, Inc. to Present at MedInvest Pharmaceutical and Biotechnology Investor Conference
PASADENA, CA, March 16, 2022 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage…
Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference
-Establishing the Camelina crop as a replenishable reserve of feedstock oil for biofuels -Winter Camelina…
BioCorRx Announces IRB Approval to Begin Phase I Clinical Trial of BICX104, an Implantable Biodegradable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, March 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates
Plans to present data at multiple scientific conferences in 2022 Expects to file INDs for…
RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
Glen Rock, N.J., March 16, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or…
Radius Health Announces Leadership Appointments
BOSTON, March 16, 2022 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:…
BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain
VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Cytovia Therapeutics to Present Preclinical Data for iPSC-derived NK Cells and Flex-NK™ Engager Multispecific Antibodies at 2022 AACR Annual Meeting
AVENTURA, Fla. and NATICK, Mass., March 16, 2022 (GLOBE NEWSWIRE) — Cytovia Therapeutics, Inc., a biopharmaceutical…
Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment
CAMBRIDGE, Mass., March 16, 2022 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)…
Palisade Bio (Nasdaq: PALI) Announces Analysis Demonstrating LB1148 Reduced the Extent and Severity of Post-Surgical Intraabdominal Adhesions by 93%
Data from Pooled-Analysis of Enteral Protease Inhibitor LB1148 Demonstrated 72% Reduction in the Risk of…
Dialco Medical Announces Formation of Medical Advisory Board to Support the Continued Development of DIMI Device
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
SOTIO Announces Oral and Multiple Poster Presentations on Key Clinical Programs at the American Association of Cancer Research Annual Meeting (AACR) 2022
Oral presentation will focus on interim efficacy and safety data from the Phase 1/1b AURELIO-03…
Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics
NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage…
Baudax Bio Reports 2021 Fourth Quarter and Annual Financial Results
Units Sold by Quarter Units Sold by Quarter Quarterly Customer Sales / Quarterly ASC Sales…
Ocuphire Completes Enrollment of Over 100 Subjects in 24-Week ZETA-1 Phase 2b Trial of Oral APX3330 for the Treatment of Diabetic Retinopathy
Successful Execution and Completion of Enrollment in Four Late-Stage Clinical Trials Across Nyxol and APX3330…
Prelude Therapeutics Reports Full Year 2021 Financial Results
Significant progress achieved in 2021: Pipeline now includes six internally discovered small molecule compounds targeting…